Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity-Reference-Cited by-同舟云学术

Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity

Published:2016-03-21 Issue:9 Volume:122 Page:1398-1407
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Schiffer Charles A.¹,Cortes Jorge E.²,Hochhaus Andreas³,Saglio Giuseppe⁴,le Coutre Philipp⁵,Porkka Kimmo⁶,Mustjoki Satu⁶,Mohamed Hesham⁷,Shah Neil P.⁸

Affiliation:

1. Barbara Ann Karmanos Cancer InstituteWayne State UniversityDetroit Michigan

2. The University of Texas M.D. Anderson Cancer CenterHouston Texas

3. Jena University HospitalJena Germany

4. San Luigi Gonaga HospitalUniversity of TurinOrbassano‐Turin Italy

5. Charite‐Campus Virchow ClinicBerlin Medical UniversityBerlin Germany

6. Department of Hematology and Hematology Research UnitHelsinki University Central Hospital Comprehensive Cancer Center, University of HelsinkiHelsinki Finland

7. Bristol‐Myers SquibbPrinceton New Jersey

8. University of California, San Francisco School of MedicineSan Francisco California

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.29933

Reference38 articles.

1. Chronic myeloid leukemia in the tyrosine kinase inhibitor era: What is the best therapy?

2. Dasatinib

3. The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib

4. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. β‐Galactosidase‐Triggered Photodynamic Elimination of Senescent Cells with a Boron Dipyrromethene‐Based Photosensitizer;Advanced Science;2024-06-17

2. Drug-induced chylothorax as a rare pleural complication in dasatinib therapy for chronic myeloid leukaemia;Journal of the Royal College of Physicians of Edinburgh;2024-03

3. A navitoclax-loaded nanodevice targeting matrix metalloproteinase-3 for the selective elimination of senescent cells;Acta Biomaterialia;2024-03

4. Some Hematological Indices as Predictors of Survival in Chronic Myeloid Leukemia Patients;Mustansiriya Medical Journal;2024-01

5. Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19;Cancers;2023-10-20